Symptomatic acute splanchnic vein thrombosis in the setting of significantly reduced kidney function presents a distinct clinical challenge. Reduced creatinine clearance directly constrains which anticoagulants can be used safely, making the choice of initial therapy a critical decision.
Symptomatic acute splanchnic vein thrombosis in a patient with creatinine clearance below 30 mL/min. When renal function is severely impaired — particularly when clearance falls below 15 mL/min — the preferred anticoagulant agent differs from the general approach.
Initial anticoagulation is recommended; the specific agent is selected based on the degree of renal impairment. Several options exist, and the full structured protocol defines which is recommended at each level of creatinine clearance — including a preferred agent for the most severely impaired patients.
Treatment goal: Highest possible vessel recanalization
DOI: 10.1111/jth.14836
In patients with symptomatic acute splanchnic vein thrombosis and creatinine clearance <30 mL/min, we recommend initial treatment with unfractionated heparin, apixaban, rivaroxaban, or half therapeutic dose LMWH; we suggest unfractionated heparin if creatinine clearance <15 mL/min.
Treatment of occlusive or non-occlusive acute splanchnic vein thrombosis aims to prevent intestinal infarction or ischemia, and achieve the highest possible vessel recanalization to reduce splanchnic hypertension and bleeding risk.
View source ↗